Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AL-MONDHIRY, H.
Right arrow Articles by GORDON, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AL-MONDHIRY, H.
Right arrow Articles by GORDON, A. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1971, Vol. 38, No. 5, pp. 576-582.
© 1971 American Society of Hematology, Inc.


Pure Red Cell Aplasia and Thymoma: Loss of Serum Inhibitor of Erythropoiesis Following Thymectomy

HAMID AL-MONDHIRY 1, ESMAIL D. ZANJANI 1, MORTON SPIVACK 1, RALPH ZALUSKY 1, and ALBERT S. GORDON 1

1 Division of Hematology, Department of Medicine, Montefiore Hospital and Medical Center, Bronx, N.Y.; The Laboratory of Experimental Hematology, Department of Biology, Graduate School of Arts and Science, New York University, New York, N. Y.; Section of Hematology, Morrisania-Montefiore Affiliation, Bronx, N. Y.; and the Department of Medicine (Hematology), Mount Sinai School of Medicine of the City University of New York, New York, N. Y.

A 32-yr-old black female with pure red cell aplasia and thymoma showed complete hematologic remission after thymectomy. Bioassay of preoperative serum and urine in exhypoxic polycythemic mice revealed the presence of significant levels of erythropoiesis-stimulating factor (ESF or erythropoietin). Antierythropoietin completely neutralized the erythropoietic effect of these samples. Utilizing both normal and exhypoxic polycythemic mice, the preoperative serum and urine were also found to contain a potent inhibitor of erythropoiesis. However, no such activity was demonstrated in saline extracts of the tumor tissue. The inhibitor was present in the serum IgG fraction. Serum to which excess ESF had been added, after prior neutralization of endogenous ESF with anti-ESF, failed to stimulate erythropoiesis in the polycythemic mouse.

Submitted on January 10, 1971
Revised on June 9, 1971
Accepted on June 15, 1971


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
E. M. Sloand, P. Scheinberg, J. Maciejewski, and N. S. Young
Brief Communication: Successful Treatment of Pure Red-Cell Aplasia with an Anti-Interleukin-2 Receptor Antibody (Daclizumab)
Ann Intern Med, February 7, 2006; 144(3): 181 - 185.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1971 by American Society of Hematology         Online ISSN: 1528-0020